ALKS Stock Analysis: Buy, Sell, or Hold?
ALKS - Alkermes Inc. plc
$34.99
-0.41 (-1.16%)
▼
5d:
+4.82%
30d:
+0.2%
90d:
+0.23%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
ALKS is down 3.5% this week, but smart money is accumulating calls. Top strike: $34 2026-06-18 with 29 OI. Call ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When ALKS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALKS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ALKS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$42.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$26.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALKS is currently trading at $34.99, which is considered slightly high relative to its 30-day fair value range of $33.00 to $35.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.5) compared to its historical average (19.3). At these levels, the market is pricing in 5.2% annual earnings growth.
Technical Outlook: Technically, ALKS is in a uptrend. Immediate support is located at $32.84, while resistance sits at $36.60.
Market Sentiment: ALKS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.24 (+29.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALKS is in a uptrend. Immediate support is located at $32.84, while resistance sits at $36.60.
Market Sentiment: ALKS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.24 (+29.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$33.00 -
$35.15
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.3% below Wall St target ($45.24)
- BULLISH: Expecting earnings turnaround to 5.2% growth with 28.2% revenue growth
Trading Range Analysis
30-Day Trading Range
$33.00 -
$35.15
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$32.84
Resistance Level
$36.60
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.48
Wall Street Target
$45.24
(+29.3%)
Revenue Growth (YoY)
28.2%
Earnings Growth (YoY)
-67.0%
Profit Margin
9.8%
Valuation Premium vs History
+5.2% premium
PE vs Historical
22.5 vs 19.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.2%
(market-implied from PE analysis)
1-Year Target
$36.81
(+5%)
2-Year Target
$38.72
(+11%)
3-Year Target
$40.74
(+16%)
3-Yr Target (if PE normalizes)
(PE: 22→19)
PE COMPRESSION
$34.97
(0%)
Earnings growth offset by PE compression
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Trailing PE: 39.33 | Current EPS (TTM): $0.90
Bull Case
$67.34
(+93%)
Analyst growth 72.9%, PE expands to 43.3
Base Case
$61.22
(+75%)
Market implied 72.9%, PE stable at 39.3
Bear Case
$24.07
(-31%)
Severe decline -20.0%, PE contracts to 33.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 10, 2026 4:24 PM ET
Data refreshes hourly during market hours. Next update: 5:24 PM
Data refreshes hourly during market hours. Next update: 5:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALKS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David Joseph Gaffin
SELL
2034 shares
2026-04-06
Craig C Hopkinson
SELL
9000 shares
2026-04-01
Christian Todd Nichols
SELL
6000 shares
2026-03-02
Featured in Portfolios
ALKS is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 66 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$102 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 52 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 54 HOLD |
Advanced ALKS Option Strategies
Professional options setups generated by AI based on today's ALKS price and gamma walls.
